Skip to main content
. 2021 Jul 14;17(1):59–66. doi: 10.5114/pg.2021.107801

Table II.

Correlation between E-cadherin expression and clinic-pathological parameters

Parameter Total (N = 100) E cadherin expression – carcinoma intensity χ2 P-value
0 1+ 2+ 3+
Age [years]:
< 45 26 4 (15.4) 10 (38.5) 8 (30.8) 4 (15.4) 4.620 0.202
> 45 74 6 (8.1) 17 (23.0) 29 (39.2) 22 (29.7)
Sex:
Male 58 9 (15.5) 15 (25.9) 20 (34.5) 14 (24.1) 4.690 0.196
Female 42 1 (2.4) 12 (28.6) 17 (40.5) 12 (28.6)
Size of tumor [cm]:
< 5 37 5 (13.5) 12 (32.4) 11 (29.7) 9 (24.3) 3.393 0.758
5–9.99 55 4 (7.3) 13 (23.6) 22 (40.0) 16 (29.1)
> 10 8 1 (12.5) 2 (25.0) 4 (50.0) 1 (12.5)
Sites:
Rectum 38 2 (5.3) 10 (26.3) 19 (50.0) 7 (18.4) 5.539 0.136
Colon 62 8 (12.9) 17 (27.4) 18 (29.3) 19 (30.6)
Tumour invasion (T status):
PT1 1 0 (0.0) 0 (0.0) 0 (0.0) 1 (100.0) 6.793 0.659
PT2 42 2 (4.8) 10 (23.8) 19 (45.2) 11 (26.2)
PT3 42 6 (14.3) 12 (28.6) 14 (33.3) 10 (23.8)
PT4 15 2 (13.3) 5 (33.3) 4 (26.7) 4 (26.7)
Lymph node involvement (N status):
NX 6 1 (16.7) 0 (0.0) 4 (66.7) 1 (16.7) 22.82 0.007
N0 54 7 (13.0) 12 (22.2) 20 (37.0) 15 (27.8)
N1 27 0 (0.0) 6 (22.2) 13 (48.1) 8 (29.6)
N2 13 2 (15.4) 9 (69.2) 0 (0.0) 2 (15.4)
Metastasis:
M0 95 26 (27.4) 36 (37.9) 24 (25.3) 9 (9.5) 4.196 0.650
M1 2 0 (0.0) 1 (50.0) 1 (50.0) 0 (0.0)
MX 3 1 (33.3) 0 (0.0) 1 (33.3) 1 (33.3)
Tumour differentiation pattern:
Poorly differentiated 13 5 (38.5) 4 (30.8) 2 (15.4) 2 (15.4) 17.131 0.009
Moderately differentiated 74 3 (4.1) 19 (25.7) 30 (40.5) 22 (29.7)
Well differentiated 13 2 (15.4) 4 (30.8) 5 (38.5) 2 (15.4)
Cytoplasm or membrane:
Negative/NA 10 10 0 (0.0) 0 (0.0) 0 (0.0) 104.32 < 0.001
Membrane 10 0 (0.0) 4 (40.0) 3 (30.0) 3 (30.0)
Cytoplasm 37 0 (0.0) 14 (37.8) 15 (40.5) 8 (21.6)
Membrane and cytoplasm 43 0 (0.0) 9 (20.9) 19 (44.2) 15 (34.9)